First Financial Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

First Financial Corp’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-200	Closed	-$28K	–	475
2016 Q1	$28K	Sell	200 -45	-18%	-$6.61K	0.01%	306
2015 Q4	$47K	Hold	245	–	–	0.02%	263
2015 Q3	$38K	Hold	245	–	–	0.02%	279
2015 Q2	$44K	Hold	245	–	–	0.02%	276
2015 Q1	$42K	Sell	245 -15	-6%	-$2.71K	0.02%	277
2014 Q4	$48K	Hold	260	–	–	0.02%	265
2014 Q3	$43K	Hold	260	–	–	0.02%	281
2014 Q2	$41K	Hold	260	–	–	0.02%	286
2014 Q1	$40K	Sell	260 -225	-46%	-$35.8K	0.02%	288
2013 Q4	$64K	Hold	485	–	–	0.03%	237
2013 Q3	$56K	Sell	485 -35	-7%	-$3.84K	0.03%	248
2013 Q2	$48K	Buy	+520	New	+$50.1K	0.02%	250

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Financial Corp's ALXN Position: Q2 2016 in Review

First Financial Corp sold out of Alexion Pharmaceuticals (ALXN) in Q2 2016, closing a stake of 200 shares — an estimated $28K sold.

First Financial Corp first reported a position in ALXN in Q2 2013 and held it in 12 quarters. The position peaked at $64K in Q4 2013. 534 funds tracked by Wall St. Rank hold ALXN as of Q2 2016.

First Financial Corp reported no remaining Alexion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
First Financial Corp sold 200 Alexion Pharmaceuticals shares in Q2 2016, an estimated $28K.
First Financial Corp first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 12 quarters.
First Financial Corp's Alexion Pharmaceuticals position peaked at $64K in Q4 2013.
534 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2016.

Based on First Financial Corp's 13F filing for Q2 2016, filed 12 Jul 2016.